Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (521-530 of 751) with videos related to

Pageof 76
Sort By:
Journal of the American College of Cardiology|July 6, 2019
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art ReviewDavide Capodanno, Kurt Huber, Roxana Mehran, et al.
Journal of Thrombosis and Thrombolysis|April 12, 2019
International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarinPatricia O Guimarães, Renato D Lopes, John H Alexander, et al.
Heart (British Cardiac Society)|January 28, 2021
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery diseaseMatthias Bossard, Peggy Gao, William Boden, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 7, 2012
Metabolic profiles predict adverse events after coronary artery bypass graftingAsad A Shah, Damian M Craig, Jacqueline K Sebek, et al.
American Heart Journal|May 22, 2012
Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery diseaseSvati H Shah, Jie-Lena Sun, Robert D Stevens, et al.
Circulation|December 21, 2018
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Journal of Thrombosis and Thrombolysis|June 25, 2005
Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committeeE Magnus Ohman, Christopher B Granger, Lawrence Rice, et al.
European Heart Journal|May 30, 2025
Pre-treatment lysis time of plasma-derived fibrin clots and bleeding in patients on oral anticoagulants for atrial fibrillation in the ARISTOTLE trialWilliam A E Parker, Thomas A Nelson, Justin Lee, et al.
Journal of Thrombosis and Thrombolysis|February 22, 2019
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE TrialJeffrey B Washam, Stefan H Hohnloser, Renato D Lopes, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 25, 2024
Effects of albiglutide on myocardial infarction and ischaemic heart disease outcomes in patients with type 2 diabetes and cardiovascular disease in the Harmony Outcomes trialKonstantin A Krychtiuk, Guillaume Marquis-Gravel, Shannon Murphy, et al.
Pageof 76

Showing results (521-530 of 751) with videos related to

Sort By:
Pageof 76
Journal of the American College of Cardiology|July 6, 2019
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art ReviewDavide Capodanno, Kurt Huber, Roxana Mehran, et al.
Journal of Thrombosis and Thrombolysis|April 12, 2019
International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarinPatricia O Guimarães, Renato D Lopes, John H Alexander, et al.
Heart (British Cardiac Society)|January 28, 2021
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery diseaseMatthias Bossard, Peggy Gao, William Boden, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 7, 2012
Metabolic profiles predict adverse events after coronary artery bypass graftingAsad A Shah, Damian M Craig, Jacqueline K Sebek, et al.
American Heart Journal|May 22, 2012
Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery diseaseSvati H Shah, Jie-Lena Sun, Robert D Stevens, et al.
Circulation|December 21, 2018
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Journal of Thrombosis and Thrombolysis|June 25, 2005
Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committeeE Magnus Ohman, Christopher B Granger, Lawrence Rice, et al.
European Heart Journal|May 30, 2025
Pre-treatment lysis time of plasma-derived fibrin clots and bleeding in patients on oral anticoagulants for atrial fibrillation in the ARISTOTLE trialWilliam A E Parker, Thomas A Nelson, Justin Lee, et al.
Journal of Thrombosis and Thrombolysis|February 22, 2019
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE TrialJeffrey B Washam, Stefan H Hohnloser, Renato D Lopes, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 25, 2024
Effects of albiglutide on myocardial infarction and ischaemic heart disease outcomes in patients with type 2 diabetes and cardiovascular disease in the Harmony Outcomes trialKonstantin A Krychtiuk, Guillaume Marquis-Gravel, Shannon Murphy, et al.
Pageof 76